Safety Considerations and Who Should Evaluate Compounded Semaglutide Compounded semaglutide is not appropriate for patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe pancreatitis, or severe gastrointestinal disease
It is not supplied for human consumption, medical use, veterinary use, clinical use or treatment purposes
As a result, compounded GLP-1 medications from 503B facilities tend to be somewhat more expensive than those from 503A pharmacies
Yamada Y, Ikeda M, Suzuki H, et al
Panagiotopoulou, and Moses S
The daily antioxidants included 6100 mg ascorbic acid, 1050 mg dl-alpha-tocopherol (a form of vitamin E), and 60 mg beta-carotene